Disclosed are compositions useful in the treatment and prevention of Hepatitis C virus (HCV) infections and the symptoms and diseases associated therewith. In particular, DNA vaccines comprising polynucleotide sequences encoding HCV proteins, and the manufacture of medicaments for the treatment of individuals infected with HCV.
展开▼